Medindia1h
Vedolizumab Outperforms Infliximab in Second-Line Therapy for Ulcerative Colitis
Vedolizumab outperforms infliximab in ulcerative colitis patients who fail first-line treatment, achieving better ...
Le Lézard21h
Trevi Therapeutics Announces Positive Topline Results from the Phase 2a RIVER Trial of Haduvio in Patients with Refractory Chronic Cough
Haduvio met the primary endpoint with a statistically-significant reduction (p<0.0001) in 24-hour cough frequency with a 57% placebo-adjusted change from baseline Haduvio showed similar efficacy in ...
PharmiWeb14h
STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...
What you should know about colorectal cancer screening options
As colorectal cancer rates rise in adults under 50, new at-home screening options offer opportunities for early detection.
Johnson & Johnson met main goal in its oral treatment trial for ulcerative colitis
Johnson & Johnson said that its mid-stage study of icotrokinra, for the treatment of moderate to severe active ulcerative ...
EatingWell on MSN12h
The #1 Food to Limit to Reduce Your Colon Cancer Risk, According to an Oncologist
The #1 Food to Limit to Lower Colon Cancer Risk. Making an effort to reduce colorectal cancer risk is important, and limiting ...